NCT00435461View on ClinicalTrials.gov

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

PHASE4CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 20, 2006

Primary Completion Date

February 1, 2007

Study Completion Date

February 28, 2007

Conditions
Rhinitis, Allergic, Seasonal
Interventions
DRUG

Fluticasone furoate and fexofenadine

Fluticasone furoate and fexofenadine

Trial Locations (6)

78028

GSK Investigational Site, Kerrville

78130

GSK Investigational Site, New Braunfels

78205

GSK Investigational Site, San Antonio

78229

GSK Investigational Site, San Antonio

78731

GSK Investigational Site, Austin

78750

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00435461 - Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine | Biotech Hunter | Biotech Hunter